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LETTERS TO THE EDITOR
Defining Stent
Thrombosis: Whose Definition to Use?
In their single-center registry, Orford et al. (1) considered stent
thrombosis to have occurred when death was sudden and unex-
plained (11 patients), when a myocardial infarction (MI) occurred
in the territory of the treated vessel (9 patients), or, in one case, on
the basis of diagnostic angiography alone. Two patients did not
fulfill these criteria, but were inexplicably included in the stent
thrombosis group. The investigators conclude that, when stent
thrombosis occurs, the majority of patients either die or have a
nonfatal MI; however, this is only a consequence of the definition
of stent thrombosis used by the investigators.
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REPLY
We appreciate the comments and acknowledge the concerns of Dr.
Martı´nez-Selle´s regarding the diagnosis of stent thrombosis in our
analysis of the Mayo Clinic registry (1). It may be quite reasonably
argued that a definitive diagnosis of stent thrombosis requires
angiographic confirmation, perhaps with even angioscopic evi-
dence of thrombus, or autopsy (2). If this had been feasible, it is
likely that a number of cases that we considered to represent stent
thrombosis would not have been attributable to thrombotic occlu-
sion within the stent. Similarly, although stent thrombosis is a
highly morbid event that results in Q-wave infarction and death in
the majority of cases, it is also possible that some cases of stent
thrombosis might have occurred subclinically and been missed in
our analysis.
However, our interest in this pathologic entity arises primarily
from the clinical sequelae of this complication. Therefore, we
considered all patients to have had stent thrombosis when it was
confirmed angiographically, when a myocardial infarction (MI)
(ST- or non–ST segment elevation) occurred in the territory of the
treated vessel and stent thrombosis could not be definitively
excluded, or when death was sudden and unexplained, a definition
that has been widely used by others (3–9). Therefore, although Dr.
Martı´nez-Selle´s is correct that we may have both included some
cases not due to stent thrombosis and missed some that were, such
a definition using “hard” end points is both practical and allows for
sensible comparisons of preventative and therapeutic strategies,
and we believed it would be most suitable for this study of
frequency and correlates of this complication of percutaneous
coronary intervention.
Finally, we must thank Dr. Martı´nez-Selle´s for allowing us to
clarify the outcomes associated with stent thrombosis in our
population. There were in fact three cases of stent thrombosis
without MI or death that were diagnosed by coronary angiogra-
phy, not one. We apologize for this error.
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Calculating the Absolute
Value of the Mean Left Atrial
Maximal and Minimal Volume
We enjoyed the study by Thomas et al. published in the Journal
(1); however, we have some concern regarding the absolute value of
the calculated mean left atrial maximal and minimal volume. In
patients without mitral regurgitation, the reservoir volume (left
atrial total emptying volume) of the left atrium represents the
amount of blood coming from the pulmonary vein during ventric-
ular systole. In the case of the younger group of the present study,
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22.5 ml of blood fills the left atrium from the pulmonary vein
during systole. Because the systolic fraction of the pulmonary vein
is 56% (of the systo-diastolic flow), we can assume that the total
flow coming from the pulmonary vein (which reflects the total
forward stroke volume) is 40 ml. Consequently, for the reported
heart rate and body surface area, the cardiac index is 1.5 l/min/m2,
which is surprisingly low for a normal patient population. This
rough calculation is enforced by the observation during trans-
esophageal echocardiography that the diameter of the pulmonary
vein does not change so much during the entire cardiac cycle. It has
been shown that left atrial volume measured by echocardiography
is underestimated compared with both cine-computed tomography
(2) and magnetic resonance imaging (3). Would it not be useful to
consider a physiologic variable such as cardiac output to evaluate
the accuracy of volume measurement?
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REPLY
We appreciate the comments that Dr. Rossi expressed concerning
our recent study (1) “Compensatory Changes in Atrial Volumes
With Normal Aging: Is Atrial Enlargement Inevitable?” We are
grateful to be given the chance to respond to the issues raised in the
letter.
Our findings demonstrated that, in the younger age group, total
left atrial volume change (passive emptying volume  conduit
volume  active emptying volume) was approximately 60 ml per
cardiac cycle. Thus, one may extrapolate that the left ventricular
stroke volume in the absence of valvular regurgitation is approxi-
mately 60 ml. For a mean heart rate of 71 beats/min and body
surface area (BSA) of 1.8 m2, the cardiac output would be 4.3
l/min or 2.4 l/min/m2, which is a reasonable estimate for the
cardiac output of a normal young patient at rest. We agree with
Dr. Rossi that correlating the left atrial volume estimation with
cardiac output may be useful. However, we elected not to include
the data, as insertion of a pulmonary artery catheter for measure-
ment of cardiac output by thermodilution in our normal volunteers
was difficult to justify. Estimating stroke volume by measuring the
time velocity integral of the left ventricular outflow tract was not
included because the main thrust of the present study was on left
atrial volume.
Furthermore, we believe that estimation of total left atrial
volume change from pulmonary venous flow, which is suggested by
Dr. Rossi, would ignore the all-important contribution of active
atrial contraction to left ventricular filling, which would lead to an
underestimation. However, we would like to emphasize that the
potential for volume underestimation is always present with
echocardiography. Thus, when estimating atrial volumes echocar-
diographically, the atrial volume should be maximized by selecting
the largest frame, including the curve of the interatrial septum.
Moreover, we would also like to mention that the biplane atrial
volumes obtained from transthoracic images do not account for
atrial appendage blood volume. This exclusion of left atrial
appendage volume may cause the underestimation in total atrial
volume. Finally, when imaging at increased depths, the use of a
lower frequency transducer may provide greater penetration,
thereby optimizing atrial border visualization.
We sincerely hope that the above will adequately address the
concern raised in Dr. Rossi’s communication.
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Coronary Artery Bypass Graft Surgery
in Patients With Recent Exposure
to Clopidogrel and Aspirin Therapy
We read with great interest the study by Hongo et al. (1) entitled
“The Effect of Clopidogrel in Combination With Aspirin When
Given Before Coronary Artery Bypass Grafting.” This very inter-
esting study highlights an emerging problem for patients having
routine coronary artery bypass graft surgery (CABG) after percu-
taneous intervention, as described in their report, but also for
patients with an acute coronary syndrome who require urgent
“in-house surgery” because these patients are invariably on both
clopidogrel and aspirin therapy.
In their study, the investigators showed that continued clopi-
dogrel therapy within seven days of elective CABG results in
increased blood loss, increased use of blood products, and increased
re-exploration rates. Unfortunately, although the study was pro-
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